Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZURDEX for Diabetic Macular Edema Post-Cataract Surgery
NCT01673191Phase 2Completed
- Sponsor
- Retinal Consultants of Arizona
- Start
- Nov 2012
- Primary completion
- Dec 2014
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ozurdex in macular edema, sponsored by Retinal Consultants of Arizona. Started Nov 2012; status: completed.
02
Drugs
ozurdex
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT01673191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673191.